DaVita
DVA
#2084
Rank
S$12.24 B
Marketcap
S$171.20
Share price
21.17%
Change (1 day)
-28.89%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.63. In 2024 the company made an earnings per share (EPS) of S$14.02 an increase over its 2023 EPS that were of S$9.67.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.10-6.52%
2024S$14.0244.94%
2023S$9.6727.26%
2022S$7.60-35.56%
2021S$11.7944.1%
2020S$8.1819.7%
2019S$6.84540.48%
2018S$1.07-76.07%
2017S$4.46-19.31%
2016S$5.53242.52%
2015S$1.61-62.87%
2014S$4.3513.43%
2013S$3.838.45%
2012S$3.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$27.13 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.02 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$18.68 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.41-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA